Received Jul 7, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | Z014724 | OT |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | — | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
she had a little bit of a fever, in which she has since recovered from; patient had came in for her 2nd dose of GARDASIL-9 and was inadvertently given 2 doses of GARDASIL-9; This Spontaneous report was received from Pharmacist and referred to a/an 31-years-old ( Race Unknown ) ( Ethnicity Unknown) Female Adult patient. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medication included Heplisav b (Hepatitis b vaccine rHBsAg (yeast)). On 30-May-2026, the patient started therapy with Human Papillomavirus Nonavalent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58; S. cerevisia... Suspension for injection 64458329:4121 (0.50 mL) (total) (Batch/Lot Number: Z014724) (Expiration date: 14-Jan-2028) dose form was Suspension for injection in pre-filled syringe via Intramuscular (Dose Text: anatomical site: deltoid). On 04-Jul-2026, the patient started therapy with human papillomavirus 9-valent vaccine, recombinant suspension for injectionAsked But Unknown Batch/Lot Number dose form was Suspension for injection. and On 04-Jul-2026, the patient started therapy with human papillomavirus 9-valent vaccine, recombinant suspension for injectionAsked But Unknown Batch/Lot Number dose form was Suspension for injection (Dose Text: extra dose). The patient started therapy with Human Papillomavirus Nonavalent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58; S. cerevisia... Suspension for injection 64458329:4121 for the treatment of Age-based protection, The patient started therapy with human papillomavirus 9-valent vaccine, recombinant suspension for injection for the treatment of Age-based protection, On 04-Jul-2026, the patient experienced she had a little bit of a fever, in which she has since recovered from (Pyrexia). On 04-Jul-2026, the patient experienced patient had came in for her 2nd dose of GARDASIL-9 and was inadvertently given 2 doses of GARDASIL-9 (Accidental overdose). Site Narrative: Caller reported that on 7/4/2026, a patient had came in for her 2nd dose of GARDASIL-9 and was inadvertently given 2 doses of GARDASIL-9. Pharmacist reported the patient noted she had a little bit of a fever, in which she has since recovered from.. In Jul-2026, the patient recovered from Pyrexia . The Outcome of Accidental overdose was not provided. The action taken with Human Papillomavirus Nonavalent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58; S. cerevisia... Suspension for injection 64458329:4121 regarding Pyrexia was Not applicable with Not Applicable dechallenge and rechallenge results. The action taken with human papillomavirus 9-valent vaccine, recombinant suspension for injection regarding Pyrexia was Not applicable with Not Applicable dechallenge and rechallenge results. Case Assessments: human papillomavirus 9-valent vaccine, recombinant suspension for injection regarding Accidental overdose with Not Applicable dechallenge and rechallenge results. Case Assessments: Human Papillomavirus Nonavalent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58; S. cerevisia... Suspension for injection 64458329:4121 regarding Accidental overdose with Not Applicable dechallenge and rechallenge results. The Pharmacist considered the event Accidental overdose (,) to be not assessed to human papillomavirus 9-valent vaccine, recombinant suspension for injection and the event Accidental overdose (,) to be not assessed to Human Papillomavirus Nonavalent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58; S. cerevisia... Suspension for injection 64458329:4121 the causality for the event Pyrexia to Human Papillomavirus Nonavalent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58; S. cerevisia... Suspension for injection 64458329:4121 was not reported, and the causality for the event Pyrexia to human papillomavirus 9-valent vaccine, recombinant suspension for injection was not reported, The Pharmacist considered the event Pyrexia to be non-serious and the event Accidental overdose to be non-serious
Hepatitis B vaccine (HEPLISAV-B)